Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
- PMID: 26491325
- PMCID: PMC4599141
- DOI: 10.2147/NDT.S88085
Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
Abstract
This study aimed to examine symptoms/demographic characteristics as predictors for psychosocial functioning among individuals with schizophrenia. The Personal and Social Performance (PSP) scale was used to assess psychosocial functioning. Other measures of interest included were the Clinical Global Impression, Severity scale, and the Marder's five-factor model of the Positive and Negative Syndrome Scale. This study included 199 participants with non-acute stage schizophrenia. Spearman correlation coefficients and stepwise multiple linear regression analyses were applied to determine the correlates and predictors of PSP domain/total scores. Younger age, earlier age of schizophrenia onset, severe illness, positive symptoms, negative symptoms, disorganized thought, hostility/excitement, and anxiety/depression were found to significantly correlate with poor functioning. Severe illness and negative symptoms are the main predictors of greater impairment of socially useful activities, personal and social relationships, and self-care. Further prospective studies in other settings, which would include an increased number of variables such as neurocognitive function and social support, are warranted.
Keywords: age; association; correlation; excitement; hostility; negative symptoms; severity.
References
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
-
- Juckel G, Morosini PL. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry. 2008;21(6):630–639. - PubMed
-
- Nasrallah HA, Targum SD, Tandon R, McCombs JS, Ross R. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatr Serv. 2005;56(3):273–282. - PubMed
-
- Suzuki T, Remington G, Mulsant BH, et al. Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation. Psychiatry Res. 2012;197(1–2):1–6. - PubMed
-
- Mueser KT. Cognitive functioning, social adjustment and long term outcome in schizophrenia. In: Sharma V, Harvey P, editors. Cognition in Schizophrenia: Impairments, Importance and Treatment Strategies. New York: Oxford University Press; 2000. pp. 157–177.
LinkOut - more resources
Full Text Sources
Miscellaneous